Fig. 1

Flow diagram of patient recruitment
TKI, tyrosine kinase inhibitor; ALK, anaplastic lymphoma kinase; EGFR, Epidermal Growth Factor Receptor
Flow diagram of patient recruitment
TKI, tyrosine kinase inhibitor; ALK, anaplastic lymphoma kinase; EGFR, Epidermal Growth Factor Receptor